Screener
Insulet PODD Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Insulet’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
| (in millions, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $801.7 | $470.5 | $1,563.4 | $891.0 |
| Revenue to related party | — | 178.6 | — | 327.1 |
| Total revenue | 801.7 | 649.1 | 1,563.4 | 1,218.1 |
| Cost of revenue | 239.1 | 196.9 | 471.8 | 356.8 |
| Gross profit | 562.6 | 452.2 | 1,091.6 | 861.3 |
| Research and development expenses | 88.1 | 73.4 | 177.8 | 133.0 |
| Selling, general and administrative expenses | 344.8 | 257.7 | 662.1 | 518.4 |
| Operating income | 129.7 | 121.1 | 251.8 | 209.9 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Insulet's total cost of revenue?
- Insulet (PODD) reported total cost of revenue of $239.1M in Q2 2026.
- How has Insulet's total cost of revenue changed year-over-year?
- Insulet's total cost of revenue increased by 21.4% year-over-year, from $196.9M to $239.1M.
- What is the long-term trend for Insulet's total cost of revenue?
- Over 4 years (2021 to 2025), Insulet's total cost of revenue has grown at a 22.0% compound annual growth rate (CAGR), from $346.7M to $768.2M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Insulet's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude